Literature DB >> 24309480

The urgent need for clinical, diagnostic, and operational research for management of Buruli ulcer in Africa.

Daniel P O'Brien1, Eric Comte2, Micaela Serafini2, Geneviève Ehounou3, Annick Antierens2, Hubert Vuagnat4, Vanessa Christinet5, Mitima D Hamani3, Philipp du Cros6.   

Abstract

Despite great advances in the diagnosis and treatment of Buruli ulcer, it is one of the least studied major neglected tropical diseases. In Africa, major constraints in the management of Buruli ulcer relate to diagnosis and treatment, and accessibility, feasibility, and delivery of services. In this Personal View, we outline key areas for clinical, diagnostic, and operational research on this disease in Africa and propose a research agenda that aims to advance the management of Buruli ulcer in Africa. A model of care is needed to increase early case detection, to diagnose the disease accurately, to simplify and improve treatment, to reduce side-effects of treatment, to deal with populations with HIV and tuberculosis appropriately, to decentralise care, and to scale up coverage in populations at risk. This approach will require commitment and support to strategically implement research by national Buruli ulcer programmes and international technical and donor organisations, combined with adaptations in programme design and advocacy. A critical next step is to build consensus for a research agenda with WHO and relevant groups experienced in Buruli ulcer care or related diseases, and we call on on them to help to turn this agenda into reality.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24309480     DOI: 10.1016/S1473-3099(13)70201-9

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  15 in total

1.  Economic inequality caused by feedbacks between poverty and the dynamics of a rare tropical disease: the case of Buruli ulcer in sub-Saharan Africa.

Authors:  Andrés Garchitorena; Calistus N Ngonghala; Jean-Francois Guegan; Gaëtan Texier; Martine Bellanger; Matthew Bonds; Benjamin Roche
Journal:  Proc Biol Sci       Date:  2015-11-07       Impact factor: 5.349

2.  Challenges Associated with Management of Buruli Ulcer/Human Immunodeficiency Virus Coinfection in a Treatment Center in Ghana: A Case Series Study.

Authors:  Joseph Tuffour; Evelyn Owusu-Mireku; Marie-Therese Ruf; Samuel Aboagye; Grace Kpeli; Victor Akuoku; Janet Pereko; Albert Paintsil; Kofi Bonney; William Ampofo; Gerd Pluschke; Dorothy Yeboah-Manu
Journal:  Am J Trop Med Hyg       Date:  2015-06-08       Impact factor: 2.345

3.  Surgical Management of Chronic Wounds in a Buruli Ulcer Endemic Area in Central Africa.

Authors:  Marc Leroy Guifo; Agnes Essiene; Marie Ngo Nsoga; Ibrahima Farikou; Eone Daniel Handy; Ernest NjihTabah
Journal:  World J Surg       Date:  2016-05       Impact factor: 3.352

4.  Clinical Epidemiology of Buruli Ulcer from Benin (2005-2013): Effect of Time-Delay to Diagnosis on Clinical Forms and Severe Phenotypes.

Authors:  Carlos Capela; Ghislain E Sopoh; Jean G Houezo; René Fiodessihoué; Ange D Dossou; Patrício Costa; Alexandra G Fraga; João F Menino; Rita Silva-Gomes; Edgard M Ouendo; Fernando Rodrigues; Jorge Pedrosa
Journal:  PLoS Negl Trop Dis       Date:  2015-09-10

5.  A Bacterial Toxin with Analgesic Properties: Hyperpolarization of DRG Neurons by Mycolactone.

Authors:  Ok-Ryul Song; Han-Byul Kim; Samuel Jouny; Isabelle Ricard; Alexandre Vandeputte; Nathalie Deboosere; Estelle Marion; Christophe J Queval; Pierre Lesport; Emmanuel Bourinet; Daniel Henrion; Seog Bae Oh; Guillaume Lebon; Guillaume Sandoz; Edouard Yeramian; Laurent Marsollier; Priscille Brodin
Journal:  Toxins (Basel)       Date:  2017-07-18       Impact factor: 4.546

Review 6.  Global and local environmental changes as drivers of Buruli ulcer emergence.

Authors:  Marine Combe; Camilla Jensen Velvin; Aaron Morris; Andres Garchitorena; Kevin Carolan; Daniel Sanhueza; Benjamin Roche; Pierre Couppié; Jean-François Guégan; Rodolphe Elie Gozlan
Journal:  Emerg Microbes Infect       Date:  2017-04-26       Impact factor: 7.163

7.  Improving clinical and epidemiological predictors of Buruli ulcer.

Authors:  Gilbert Adjimon Ayelo; Ghislain Emmanuel Sopoh; Jean-Gabin Houezo; René Fiodessihoue; Dissou Affolabi; Ange Dodji Dossou; Yves Thierry Barogui; Akpeedje Anita Carolle Wadagni; Didier Codjo Agossadou; Epco Hasker; Françoise Portaels; Bouke C de Jong; Miriam Eddyani
Journal:  PLoS Negl Trop Dis       Date:  2018-08-06

8.  Clinical features and management of a severe paradoxical reaction associated with combined treatment of Buruli ulcer and HIV co-infection.

Authors:  Franck Wanda; Patrick Nkemenang; Genevieve Ehounou; Marie Tchaton; Eric Comte; Laurence Toutous Trellu; Isabelle Masouyé; Vanessa Christinet; Daniel P O'Brien
Journal:  BMC Infect Dis       Date:  2014-07-30       Impact factor: 3.090

Review 9.  Recent advances: role of mycolactone in the pathogenesis and monitoring of Mycobacterium ulcerans infection/Buruli ulcer disease.

Authors:  Fred Stephen Sarfo; Richard Phillips; Mark Wansbrough-Jones; Rachel E Simmonds
Journal:  Cell Microbiol       Date:  2016-01       Impact factor: 3.715

10.  Wound healing: Natural history and risk factors for delay in Australian patients treated with antibiotics for Mycobacterium ulcerans disease.

Authors:  Daniel P O'Brien; N Deborah Friedman; Anthony McDonald; Peter Callan; Andrew Hughes; Aaron Walton; Eugene Athan
Journal:  PLoS Negl Trop Dis       Date:  2018-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.